Research Paper Volume 11, Issue 21 pp 9424—9441

Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease

Figure 9. BI2536 (BI) reversed the neuroprotection effect of PCA. (A) Rotarod test in control, MPTP, PCA+MPTP and PCA+MPTP+BI group. (B) Pole test in each group. (C) TH levels from SN tissues were measured by ELISA. Data were expressed as mean ± S.D., n=6; *P< 0.05, **P< 0.01 vs. control group; #P< 0.05 vs. MPTP group, &P< 0.05 vs. PCA+MPTP group.